Liba Weilin Penji (利巴韦林喷剂)利巴韦林喷剂
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东京卫制药有限公司Chinese legal name: 山东京卫制药有限公司
主要成分Active Ingredients
- 利巴韦林Liba Weilin
- 主要成份利巴韦林Recorded Chinese composition: 主要成份利巴韦林
药物知识说明
利巴韦林是一种在国家药监局注册认定的药品。该药品含有利巴韦林-e1136c4c等成分。
该药品关联的活性成分包括：利巴韦林Liba Weilin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山东京卫制药有限公司Chinese legal name: 山东京卫制药有限公司。
您可以探索含有相同成分的其他药品：利巴韦林-e1136c4c成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 利巴韦林喷剂) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 利巴韦林Liba Weilin.
Manufacturers recorded for this product: 山东京卫制药有限公司Chinese legal name: 山东京卫制药有限公司.
Explore other medicines containing the same ingredient: 利巴韦林 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 利巴韦林喷剂Recorded Chinese name: 利巴韦林喷剂
- 剂型Dosage form: 喷剂Recorded Chinese dosage form
- 规格Specification: 16g16 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山东京卫制药有限公司Chinese legal name: 山东京卫制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20093066
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20093066
Manufacturer
Chinese legal name: 山东京卫制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20093066
生产企业
山东京卫制药有限公司(国产)
适应症
抗病毒药。本品用于流行性感冒。
用法用量
喷雾吸入，喷入鼻腔与咽喉。每4～5小时一次，鼻腔一喷，咽喉1～2喷。
不良反应
本品毒性低，口服给药的不良反应有贫血、乏力等，停药后消失。较少见的不良反应有疲倦、头痛、失眠等，多见于应用大剂量者，以及食欲减退、恶心等。
禁忌
1、对本品中任何成分过敏者禁用。|2、孕妇禁用。|3、禁用于有自身免疫性肝炎患者。
注意事项
1. 致癌与致突变:动物实验发现本品可诱发乳房、胰腺、脑垂体和肾上腺良性肿瘤，但对人体的致癌性并未肯定。利巴韦林对仓鼠等动物可引起头颅、腭、眼、颌、骨骼和胃肠道的畸形，子代成活减少。但灵长类动物实验并未发现药物对胎仔的影响。|2. 有严重贫血者或对本品敏感者慎用。
贮藏
密封。
规格
16g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.